During the World Congress Against the Death Penalty, held in Geneva PACE Rapporteur on the question of abolishing the death penalty Renate Wohlwend suggested that Japan and the United States as observers at the Council of Europe, to join the “movement for the abolition of this barbaric punishment “.
PACE continues to strictly monitor the implementation of the ban on the death penalty. Currently, she is trying to extend it to countries that have observer status with the Council of Europe. This in particular applies to the U.S. and Japan ( ed. – in February this year the Government of Japan announced the results of the study: more than 85.6% of Japanese favor of retaining the death penalty, only 5,7% – against) .
“Certainly, PACE has already considered the possibility of recommending to withdraw from the U.S. and Japan observer status with the Council of Europe. But as far as it will help the cause, prohibition the death penalty? “I believe that such a” sanction “simply spur retentsionalnye those political forces that could benefit from some of the European perception of arrogance” – she said.
Currently, Europe is the world”s only region in which almost everywhere the death penalty is prohibited by law. All 47 member states of the Council of Europe have abolished or a moratorium on the death penalty.
Tip of Europe comes from the fact that the death penalty has no place in a democratic society. Such a position the organization in 1983 resulted in the adoption, on the initiative of the PACE protocol N 6 to the European Convention on Human Rights to abolish the death penalty in peacetime. Read more »
LONDON (Reuters) – Since the drug for male impotence, Viagra exploded on the global market for pharmaceuticals, laboratories are seeking an equivalent for women. Little Pill blue made by the U.S. giant has revolutionized the sex lives of many people frustrated, and the possibility that a pill do the same for women”s libido and economic expectations generated enthusiasm among drug developers.
Still, the strong initiative of the German company Boehringer Ingelheiml, current leader of this race with its experimental product flibanserin, is attracting other women passions among some health experts.
A survey funded by the firm and released this week sought to demonstrate the emotional impact and distress experienced by women due to the lack of sexual desire.
But the work infuriated critics . Some believe that this is an attempt to position the absence or reduction of the female libido as a medical disorder. This, they say, threatens to stereotype the problem and makes women feel they have a deficiency. “The idea that the lack of sexual interest should be treated with a pill immediately implies that the multiple factors contributing to sexual problems might be overlooked, resulting that the medication is ineffective, “said Lisa Martinez, founder of the Foundation of Women”s Sexual Health, an international group based in the United States. “The medication may be the right treatment, but can not be. It depends on what the true cause of the lack of desire. If a woman is tired, distressed and need help raising their children, the pill is not the answer, “he said. In this case, the solution would be to decrease their level of fatigue and get help at home to raise their children, he said. Boehringer says it ran into the effects of flibanserin, a serotonin modulator, while investigating the chemical as a potential antidepressant. CLASSIFY THE lack of libido Martinez and other experts fear it will generate excessive medicalization of sex, a phenomenon that could inundate many couples rooms with patented pills, potions and creams. Read more »
Main News | admin | 
February 28, 2010 3:29 pm | 
Comments (0) 
Subscribe